NFκB pathway: A good signaling paradigm and therapeutic target

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 10, 2006, Pages 1647-1653

  Tergaonkar, Vinay ^a  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

I B; IKK; NEMO; NF B; p65; TRAF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE IDENTIFICATION; GENE TARGETING; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; LIGAND BINDING; NONHUMAN; PLEIOTROPY; PROMOTER REGION; RECEPTOR BINDING; SHORT SURVEY; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; DRUG DESIGN; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; REVIEW;

BACTERIA (MICROORGANISMS);

ANIMALS; DRUG DESIGN; GENE EXPRESSION REGULATION; HUMANS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 33745342580     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.03.023     Document Type: Short Survey

References (36)

1. Aggarwal B.B. Nuclear factor-kappaB: The enemy within. Cancer Cell 6 (2004) 203-208
2. Ben Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat. Immunol. 3 (2002) 20-26
3. Brummelkamp T.R., Nijman S.M., Dirac A.M., and Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424 (2003) 797-801
4. Chen L.F., and Greene W.C. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell. Biol. 5 (2004) 392-401
5. Chen Z.J. Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell. Biol. 7 (2005) 758-765
6. Chen-Park F.E., Huang D.B., Noro B., Thanos D., and Ghosh G. The kappa B DNA sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription. J. Biol. Chem. 277 (2002) 24701-24708
7. Correa R.G., Matsui T., Tergaonkar V., Rodriguez-Esteban C., Izpisua-Belmonte J.C., and Verma I.M. Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity. Curr. Biol. 15 (2005) 1291-1295
8. Courtois G. The NF-kappaB signaling pathway in human genetic diseases. Cell Mol. Life Sci. 62 (2005) 1682-1691
9. Delhase M., Hayakawa M., Chen Y., and Karin M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284 (1999) 309-313
10. Drier E.A., Huang L.H., and Steward R. Nuclear import of the drosophila rel protein dorsal is regulated by phosphorylation. Genes Dev. 13 (1999) 556-568
11. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl (2002) S81-S96
12. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
13. Hoberg J.E., Yeung F., and Mayo M.W. SMRT derepression by the IkappaB kinase alpha: A prerequisite to NF-kappaB transcription and survival. Mol. Cell 16 (2004) 245-255
14. Huang T.T., Wuerzberger-Davis S.M., Wu Z.H., and Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115 (2003) 565-576
15. Jiang J., and Levine M. Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen. Cell 72 (1993) 741-752
16. Karin M., and Ben Neriah Y. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
17. Lawrence T., Bebien M., Liu G.Y., Nizet V., and Karin M. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434 (2005) 1138-1143
18. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2 (2002) 725-734
19. Lucas P.C., McAllister-Lucas L.M., and Nunez G. NF-kappaB signaling in lymphocytes: A new cast of characters. J. Cell Sci. 117 (2004) 31-39
20. Nakanishi C., and Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat. Rev. Cancer 5 (2005) 297-309
21. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Ontogeny 18 (1999) 6853-6866
22. Perkins N.D. Regulation of NF-kappaB by atypical activators and tumour suppressors. Brioche. Soc. Trans. 32 (2004) 936-939
23. Ruland J., and Mak T.W. Transducing signals from antigen receptors to nuclear factor kappaB. Immunol. Rev. 193 (2003) 93-100
24. Saccani S., Marazzi I., Beg A.A., and Natoli G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J. Exp. Med. 200 (2004) 107-113
25. Saccani S., Pantano S., and Natoli G. Modulation of NF-kappaB activity by exchange of dimers. Mol. Cell 11 (2003) 1563-1574
26. Shim J.H., Xiao C., Paschal A.E., Bailey S.T., Rao P., Hayden M.S., et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19 (2005) 2668-2681
27. Silverman N., and Maniatis T. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15 (2001) 2321-2342
28. Sitcheran R., Cogswell P.C., and Baldwin Jr. A.S. NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev. 17 (2003) 2368-2373
29. Smahi A., Courtois G., Rabia S.H., Doffinger R., Bodemer C., Munnich A., et al. The NF-kappaB signalling pathway in human diseases: From incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum. Mol. Genet. 11 (2002) 2371-2375
30. St Johnston D. The art and design of genetic screens: Drosophila melanogaster. Nat. Rev. Genet. 3 (2002) 176-188
31. Tergaonkar V., Bottero V., Ikawa M., Li Q., and Verma I.M. IkappaB kinase-independent IkappaBalpha degradation pathway: Functional NF-kappaB activity and implications for cancer therapy. Mol. Cell Biol. 23 (2003) 8070-8083
32. Tergaonkar V., Correa R.G., Ikawa M., and Verma I.M. Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nat. Cell Biol. 7 (2005) 921-923
33. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4 (2004) 348-359
34. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., and Miyamoto S. Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation. Genes Dev. 9 (1995) 2723-2735
35. Viatour P., Merville M.P., Bours V., and Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: Implications in cancer and inflammation. Trends Brioche. Sci. 30 (2005) 43-52
36. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430 (2004) 694-699